BUZZ-GoodRx Holdings one of the most undervalued stocks, Leerink says

Reuters11-20 20:28

** Leerink Partners says digital healthcare platform GoodRx Holdings' shares are significantly undervalued when accounting for co's profit growth

** Market focus after co reported Q3 earnings has been on revenue growth in prescription marketplace, which is linked with retail store closures and ongoing negotiations with pharmacy benefit managers, says brokerage

** "However, there was almost no focus on the continued pacing of EBITDA growth, which has consistently outpaced expectations so far in FY24 and which is expected to remain steady even with potential market-driven revenue softness," says Leerink

** Contracts with Cigna's Express Scripts, CVS' Caremark and others will contribute to co's FY25 earnings, brokerage says

** Brokerage says GDRX is trading at a discount compared with stocks in NASDAQ 100 index

** As of last close, stock has fallen 36.7% YTD vs ~23% rise in

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment